Cost Analysis of Insulin Degludec in Comparison With Insulin Glargine U100 in the Treatment of Type 1 Diabetes Mellitus in the Brazilian Private Health Care System
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1285
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV